Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4229 (114th)

Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

referredUnited States· United States Congress· EN

Introduced

10 December 2015

Last action

15 January 2016 · Referred

Status

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Sponsors

Rep. Katko, John [R-NY-24], Rep. Cicilline, David N. [D-RI-1], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Gowdy, Trey [R-SC-4], Rep. Sensenbrenner, F. James, Jr. [R-WI-5], Rep. Marino, Tom [R-PA-10], Rep. Gibson, Christopher P. [R-NY-19], Rep. Dent, Charles W. [R-PA-15], Rep. Peters, Scott H. [D-CA-50], Rep. Deutch, Theodore E. [D-FL-22], Rep. Walters, Mimi [R-CA-45], Rep. Langevin, James R. [D-RI-2], Rep. Kuster, Ann M. [D-NH-2], Rep. Meehan, Patrick [R-PA-7], Rep. Jenkins, Lynn [R-KS-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Carlos Curbelo, Rep. Donovan, Daniel M., Jr. [R-NY-11], Rep. King, Peter T. [R-NY-2], Rep. Costello, Ryan A. [R-PA-6], Rep. Stefanik, Elise M. [R-NY-21], Rep. Emmer, Tom [R-MN-6], Rep. Comstock, Barbara [R-VA-10], Rep. Chabot, Steve [R-OH-1], Rep. Bishop, Mike [R-MI-8], Rep. Ashford, Brad [D-NE-2], Rep. Walberg, Tim [R-MI-5], Rep. Joyce, David P. [R-OH-14], Rep. Hanna, Richard L. [R-NY-22], Rep. Dold, Robert J. [R-IL-10], Rep. Chu, Judy [D-CA-28], Rep. Poliquin, Bruce [R-ME-2], Rep. Rooney, Thomas J. [R-FL-17], Rep. Hastings, Alcee L. [D-FL-20], Rep. Velázquez, Nydia M. [D-NY-7]

Subjects

Discovery layer

Source updated

14 January 2026

Official sourceDownload fileView documentsShare

Summary

Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 This bill amends the Controlled Substances Act to include in the definition of a "controlled substance analogue" a substance designated as such by the Controlled Substance Analogue Committee (established by this bill). It directs the Drug Enforcement Administration (DEA) to establish such Committee as an interagency committee headed by the DEA and comprised of scientific experts in the fields of chemistry and pharmacology from the DEA, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and any other federal agency determined by the DEA to be appropriate. The Committee may designate, and shall establish and maintain a list of, controlled substance analogues determined to be similar to a schedule I or II controlled substance in either chemical structure or predictive effect on the body in such a manner as to make it likely that the substance will, or can be reasonably expected to, have a potential for abuse. The DEA must publish a description of each designation made by the Committee. The bill amends the Controlled Substances Import and Export Act to prohibit the importation of any controlled substance analogue except pursuant to such notification or declaration as the DEA may prescribe. It directs the U.S. Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements to ensure that they provide adequate penalties for any offense involving the unlawful manufacturing, importing, exporting, or trafficking of controlled substance analogues and similar offenses.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 10 December 2015

    Introduced

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 10 December 2015

    Introduced

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 10 December 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 10 December 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 11 December 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 15 January 2016

    Referred

    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 10 December 2015

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 10 December 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 10 December 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.